Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation

NCT05579678 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05579678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05579678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2022
Completion date
August 31, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic disease